Literature DB >> 20200229

Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.

Simone Radtke1, Stefan Wüller, Xiang-ping Yang, Barbara E Lippok, Barbara Mütze, Christine Mais, Hildegard Schmitz-Van de Leur, Johannes G Bode, Matthias Gaestel, Peter C Heinrich, Iris Behrmann, Fred Schaper, Heike M Hermanns.   

Abstract

The inflammatory response involves a complex interplay of different cytokines which act in an auto- or paracrine manner to induce the so-called acute phase response. Cytokines are known to crosstalk on multiple levels, for instance by regulating the mRNA stability of targeted cytokines through activation of the p38-MAPK pathway. In our study we discovered a new mechanism that answers the long-standing question how pro-inflammatory cytokines and environmental stress restrict immediate signalling of interleukin (IL)-6-type cytokines. We show that p38, activated by IL-1beta, TNFalpha or environmental stress, impairs IL-6-induced JAK/STAT signalling through phosphorylation of the common cytokine receptor subunit gp130 and its subsequent internalisation and degradation. We identify MK2 as the kinase that phosphorylates serine 782 in the cytoplasmic part of gp130. Consequently, inhibition of p38 or MK2, deletion of MK2 or mutation of crucial amino acids within the MK2 target site or the di-leucine internalisation motif blocks receptor depletion and restores IL-6-dependent STAT activation as well as gene induction. Hence, a novel negative crosstalk mechanism for cytokine signalling is described, where cytokine receptor turnover is regulated in trans by pro-inflammatory cytokines and stress stimuli to coordinate the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200229     DOI: 10.1242/jcs.065326

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  38 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

2.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

Review 3.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

4.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

5.  p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.

Authors:  Adam Freund; Christopher K Patil; Judith Campisi
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

6.  Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.

Authors:  Miloslav Kverka; Jonathan M Hartley; Te-Wei Chu; Jiyuan Yang; Regina Heidchen; Jindřich Kopeček
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

7.  Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model.

Authors:  Antonio Pinto; Annika Jahn; Moritz Benjamin Immohr; Alexander Jenke; Laura Döhrn; Markus Kornfeld; Artur Lichtenberg; Payam Akhyari; Udo Boeken
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

8.  Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.

Authors:  Maria M Costa; Tiehui Wang; Milena M Monte; Christopher J Secombes
Journal:  Immunogenetics       Date:  2011-10-29       Impact factor: 2.846

9.  Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue.

Authors:  Esther Titos; Bibiana Rius; Cristina López-Vicario; José Alcaraz-Quiles; Verónica García-Alonso; Aritz Lopategi; Jesmond Dalli; Juan José Lozano; Vicente Arroyo; Salvadora Delgado; Charles N Serhan; Joan Clària
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

10.  Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.

Authors:  Xuzhang Lu; Zhichao Zhu; Lijia Jiang; Xiao Sun; Zhuxia Jia; Sixuan Qian; Jianyong Li; Lingdi Ma
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.